title: Effects of moderate exercise and oat beta-glucan on lung tumor metastases and macrophage antitumor cytotoxicity.
abstract: Both moderate exercise and the soluble fiber beta-glucan can have beneficial effects on the initiation and growth of tumors, but the data are limited, and there is no information on their combined effects. This study tested the independent and combined effects of short-term moderate-exercise training and the soluble oat fiber beta-glucan (ObetaG) on the metatastic spread of injected tumor cells and macrophage antitumor cytotoxicity. Male C57BL/6 mice were assigned to one of four groups: exercise (Ex)-H2O, Ex-ObetaG, control (Con)-H2O, or Con-ObetaG. ObetaG was fed in the drinking water for 10 days before tumor administration and death. Exercise consisted of treadmill running (1 h/day) for 6 days. After rest or exercise on the last day of training, syngeneic B16 melanoma cells (2 x 10(5)) were administered via intravenous injection (n = 8-11 per group). Lungs were removed 14 days later, and tumor foci were counted. Additional mice (n = 8 per group) were killed, and peritoneal macrophages were assayed for cytotoxicity against the same mouse tumor cell line at various effector-to-target ratios. Both moderate exercise and ObetaG decreased lung tumor foci and increased macrophage cytotoxicity. However, there were no differences in lung tumor foci and macrophage cytotoxicity between Ex-ObetaG and either Ex-H2O or Con-ObetaG. These data suggest that, although not additive in their effects, both short-term moderate-exercise training and consumption of the soluble ObetaG can decrease the metatastic spread of injected B16 melanoma cells, and these effects may be mediated in part by an increase in macrophage cytotoxicity to B16 melanoma.
authors.affiliation: Department of Exercise Science, Arnold School of Public Health, University of South Carolina, Columbia, South Carolina 29208, USA.
authors.forename: E A
authors.initials: EA
authors.lastname: Murphy
authors.forename: J M
authors.initials: JM
authors.lastname: Davis
authors.forename: A S
authors.initials: AS
authors.lastname: Brown
authors.forename: M D
authors.initials: MD
authors.lastname: Carmichael
authors.forename: E P
authors.initials: EP
authors.lastname: Mayer
authors.forename: A
authors.initials: A
authors.lastname: Ghaffar
mesh_terms: D000284:Administration, Oral; D000818:Animals; D003131:Combined Modality Therapy; D003602:Cytotoxicity, Immunologic / Q000187:drug effects / Q000276:immunology*; D019587:Dietary Supplements; D005081:Exercise Therapy / Q000379:methods*; D008175:Lung Neoplasms / Q000276:immunology / Q000517:prevention & control / Q000556:secondary* / Q000628:therapy*; D008262:Macrophage Activation / Q000187:drug effects / Q000276:immunology*; D008297:Male; D008545:Melanoma / Q000276:immunology / Q000517:prevention & control / Q000556:secondary / Q000628:therapy; D051379:Mice; D008810:Mice, Inbred C57BL; D010805:Physical Conditioning, Animal / Q000379:methods; D016896:Treatment Outcome; D047071:beta-Glucans / Q000627:therapeutic use*
chemical_list: D047071:beta-Glucans; C067858:beta-glucan, (1-3)(1-4)-